KPIs & Operating Metrics(New)
Breakdown Of AssetsEmployee StatisticsGross Margin %Gross ProfitIncome Before Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Number Of Billable Tests DeliveredOpex As A % Of RevenueOPEX BreakdownOther Current Assets BreakdownProperty And Equipment BreakdownRevenue By PayorRevenue By Payor %Revenue By Payor AnnualRevenue By Payor Annual %Revenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Gross Profit (2016 - 2025)

Historic Gross Profit for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $35.5 million.

  • Fulgent Genetics' Gross Profit rose 3265.1% to $35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.1 million, marking a year-over-year increase of 2937.22%. This contributed to the annual value of $107.2 million for FY2024, which is 264.13% up from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Gross Profit is $35.5 million, which was up 3265.1% from $34.4 million recorded in Q2 2025.
  • Fulgent Genetics' Gross Profit's 5-year high stood at $285.4 million during Q1 2021, with a 5-year trough of $13.0 million in Q4 2022.
  • Over the past 5 years, Fulgent Genetics' median Gross Profit value was $34.4 million (recorded in 2025), while the average stood at $76.5 million.
  • As far as peak fluctuations go, Fulgent Genetics' Gross Profit surged by 762061.69% in 2021, and later tumbled by 9314.8% in 2022.
  • Quarter analysis of 5 years shows Fulgent Genetics' Gross Profit stood at $189.5 million in 2021, then crashed by 93.15% to $13.0 million in 2022, then skyrocketed by 94.26% to $25.2 million in 2023, then increased by 26.24% to $31.8 million in 2024, then grew by 11.5% to $35.5 million in 2025.
  • Its Gross Profit stands at $35.5 million for Q3 2025, versus $34.4 million for Q2 2025 and $28.3 million for Q1 2025.